Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8851609rdf:typepubmed:Citationlld:pubmed
pubmed-article:8851609lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:8851609lifeskim:mentionsumls-concept:C0206427lld:lifeskim
pubmed-article:8851609lifeskim:mentionsumls-concept:C0007559lld:lifeskim
pubmed-article:8851609lifeskim:mentionsumls-concept:C0008809lld:lifeskim
pubmed-article:8851609lifeskim:mentionsumls-concept:C0020933lld:lifeskim
pubmed-article:8851609lifeskim:mentionsumls-concept:C0028902lld:lifeskim
pubmed-article:8851609lifeskim:mentionsumls-concept:C0031955lld:lifeskim
pubmed-article:8851609lifeskim:mentionsumls-concept:C0041044lld:lifeskim
pubmed-article:8851609lifeskim:mentionsumls-concept:C0282386lld:lifeskim
pubmed-article:8851609lifeskim:mentionsumls-concept:C0052585lld:lifeskim
pubmed-article:8851609lifeskim:mentionsumls-concept:C0250480lld:lifeskim
pubmed-article:8851609pubmed:issue3lld:pubmed
pubmed-article:8851609pubmed:dateCreated1997-1-7lld:pubmed
pubmed-article:8851609pubmed:abstractTextAgar dilution MICs of 10 agents against 410 non-Pseudomonas aeruginosa gram-negative nonfermentative rods were determined. MICs at which 50 and 90% of the isolates were inhibited, respectively, were as follows (in micrograms per milliliter): sparfloxacin, 0.5 and 8.0; levofloxacin, 1.0 and 8.0; ciprofloxacin, 2.0 and 32.0; ofloxacin, 2.0 and 32.0; D-ofloxacin, 32.0 and > 64.0; ceftazidime, 8.0 and 64.0; piperacillin with or without tazobactam, 16.0 and > 64.0; trimethoprim-sulfamethoxazole, 0.5 and > 64.0; imipenem, 2.0 and > 64.0. With the exception of those for Stenotrophomonas maltophilia, Burkholderia cepacia, and Alcaligenes faecalis-A. odorans, agar dilution MICs for all strains tested were within 1 dilution of inhibitory (bacteriostatic) levels as determined by time-kill methodology.lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:languageenglld:pubmed
pubmed-article:8851609pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:citationSubsetIMlld:pubmed
pubmed-article:8851609pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851609pubmed:statusMEDLINElld:pubmed
pubmed-article:8851609pubmed:monthMarlld:pubmed
pubmed-article:8851609pubmed:issn0066-4804lld:pubmed
pubmed-article:8851609pubmed:authorpubmed-author:JacobsM RMRlld:pubmed
pubmed-article:8851609pubmed:authorpubmed-author:AppelbaumP...lld:pubmed
pubmed-article:8851609pubmed:authorpubmed-author:SpanglerS KSKlld:pubmed
pubmed-article:8851609pubmed:authorpubmed-author:VisalliM AMAlld:pubmed
pubmed-article:8851609pubmed:issnTypePrintlld:pubmed
pubmed-article:8851609pubmed:volume40lld:pubmed
pubmed-article:8851609pubmed:ownerNLMlld:pubmed
pubmed-article:8851609pubmed:authorsCompleteYlld:pubmed
pubmed-article:8851609pubmed:pagination772-5lld:pubmed
pubmed-article:8851609pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:8851609pubmed:meshHeadingpubmed-meshheading:8851609-...lld:pubmed
pubmed-article:8851609pubmed:meshHeadingpubmed-meshheading:8851609-...lld:pubmed
pubmed-article:8851609pubmed:meshHeadingpubmed-meshheading:8851609-...lld:pubmed
pubmed-article:8851609pubmed:meshHeadingpubmed-meshheading:8851609-...lld:pubmed
pubmed-article:8851609pubmed:meshHeadingpubmed-meshheading:8851609-...lld:pubmed
pubmed-article:8851609pubmed:meshHeadingpubmed-meshheading:8851609-...lld:pubmed
pubmed-article:8851609pubmed:meshHeadingpubmed-meshheading:8851609-...lld:pubmed
pubmed-article:8851609pubmed:meshHeadingpubmed-meshheading:8851609-...lld:pubmed
pubmed-article:8851609pubmed:year1996lld:pubmed
pubmed-article:8851609pubmed:articleTitleSusceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem.lld:pubmed
pubmed-article:8851609pubmed:affiliationDepartment of Pathology (Clinical Microbiology), Hershey Medical Center, Pennsylvania 17033, USA.lld:pubmed
pubmed-article:8851609pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8851609pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8851609lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8851609lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8851609lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8851609lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8851609lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8851609lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8851609lld:pubmed